Literature DB >> 18185527

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.

K Stamatopoulos, T Papadaki, C Pontikoglou, I Athanasiadou, N Stavroyianni, J Bux, I Batsis, K Pyrovolaki, G Paterakis, D Anagnostou, A Anagnostopoulos, H A Papadaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18185527     DOI： 10.1038/sj.leu.2405077

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.

Authors:  Zachariah McIver; Nicole Stephens; Andrew Grim; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

2.  Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine.

Authors:  Ramon Diez-Feijóo; Juan Jose Rodríguez-Sevilla; Concepcion Fernández-Rodríguez; Solange Flores; Carmen Raya; Ana Ferrer; Luis Colomo; Antonio Salar
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

3.  Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.

Authors:  Louise Bouard; Benoit Tessoulin; Catherine Thieblemont; Kamal Bouabdallah; Thomas Gastinne; Lucie Oberic; Sylvain Carras; Caroline Delette; Olivier Casasnovas; Caroline Dartigeas; Victoria Cacheux; Sibylle Masse; Olivier Hermine; Steven Le Gouill
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047

4.  Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.

Authors:  Reza Zonozi; Zachary S Wallace; Karen Laliberte; Noah R Huizenga; Jillian M Rosenthal; Eugene P Rhee; Frank B Cortazar; John L Niles
Journal:  Arthritis Rheumatol       Date:  2020-12-29       Impact factor: 10.995

Review 5.  Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.

Authors:  C Giraud; Z Tatar; M Soubrier
Journal:  Clin Rheumatol       Date:  2016-08-19       Impact factor: 2.980

6.  Large granular lymphocyte expansions in primary Sjögren's syndrome: characteristics and outcomes.

Authors:  Alistair Baber; Gaetane Nocturne; Xavier Mariette; Raphaele Seror; Roman Krzysiek; Julien Henry; Rakiba Belkhir
Journal:  RMD Open       Date:  2019-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.